Condensed Statements of Stockholders' Equity - USD ($)	Common Stock	Accumulated Deficit	Total
Balance at Dec. 31, 2018	$ 33,951,249	$ (33,974,547)	$ (23,298)
Balance (in shares) at Dec. 31, 2018	16,665,661
Sale of common stock	$ 12,581		12,581
Sale of common stock (in shares)	314,525
Net loss for the three months ended		(11,263)	(11,263)
Balance at Mar. 31, 2019	$ 33,963,830	(33,985,810)	(21,980)
Balance (in shares) at Mar. 31, 2019	16,980,186
Balance at Dec. 31, 2018	$ 33,951,249	(33,974,547)	(23,298)
Balance (in shares) at Dec. 31, 2018	16,665,661
Net loss for the three months ended			(14,327)
Balance at Jun. 30, 2019	$ 33,965,869	(33,988,874)	(23,005)
Balance (in shares) at Jun. 30, 2019	17,031,161
Balance at Mar. 31, 2019	$ 33,963,830	(33,985,810)	(21,980)
Balance (in shares) at Mar. 31, 2019	16,980,186
Sale of common stock	$ 2,039		2,039
Sale of common stock (in shares)	50,975
Net loss for the three months ended		(3,064)	(3,064)
Balance at Jun. 30, 2019	$ 33,965,869	(33,988,874)	(23,005)
Balance (in shares) at Jun. 30, 2019	17,031,161
Balance at Dec. 31, 2019	$ 33,971,238	(33,994,967)	(23,729)
Balance (in shares) at Dec. 31, 2019	17,195,683
Sale of common stock	$ 13,500		13,500
Sale of common stock (in shares)	225,000
Net loss for the three months ended		(11,780)	(11,780)
Balance at Mar. 31, 2020	$ 33,984,738	(34,006,747)	(22,009)
Balance (in shares) at Mar. 31, 2020	17,420,683
Balance at Dec. 31, 2019	$ 33,971,238	(33,994,967)	(23,729)
Balance (in shares) at Dec. 31, 2019	17,195,683
Net loss for the three months ended			(16,062)
Balance at Jun. 30, 2020	$ 33,986,718	(34,011,029)	(24,311)
Balance (in shares) at Jun. 30, 2020	17,451,600
Balance at Mar. 31, 2020	$ 33,984,738	(34,006,747)	(22,009)
Balance (in shares) at Mar. 31, 2020	17,420,683
Sale of common stock	$ 1,980		1,980
Sale of common stock (in shares)	30,917
Net loss for the three months ended		(4,282)	(4,282)
Balance at Jun. 30, 2020	$ 33,986,718	$ (34,011,029)	$ (24,311)
Balance (in shares) at Jun. 30, 2020	17,451,600